Hypersensitivity vasculitis

Revision as of 16:10, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Hypersensitivity vasculitis
ICD-10 M31.0
ICD-9 446.2
DiseasesDB 7423
eMedicine med/2930 
MeSH C14.907.940.910

WikiDoc Resources for Hypersensitivity vasculitis

Articles

Most recent articles on Hypersensitivity vasculitis

Most cited articles on Hypersensitivity vasculitis

Review articles on Hypersensitivity vasculitis

Articles on Hypersensitivity vasculitis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hypersensitivity vasculitis

Images of Hypersensitivity vasculitis

Photos of Hypersensitivity vasculitis

Podcasts & MP3s on Hypersensitivity vasculitis

Videos on Hypersensitivity vasculitis

Evidence Based Medicine

Cochrane Collaboration on Hypersensitivity vasculitis

Bandolier on Hypersensitivity vasculitis

TRIP on Hypersensitivity vasculitis

Clinical Trials

Ongoing Trials on Hypersensitivity vasculitis at Clinical Trials.gov

Trial results on Hypersensitivity vasculitis

Clinical Trials on Hypersensitivity vasculitis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hypersensitivity vasculitis

NICE Guidance on Hypersensitivity vasculitis

NHS PRODIGY Guidance

FDA on Hypersensitivity vasculitis

CDC on Hypersensitivity vasculitis

Books

Books on Hypersensitivity vasculitis

News

Hypersensitivity vasculitis in the news

Be alerted to news on Hypersensitivity vasculitis

News trends on Hypersensitivity vasculitis

Commentary

Blogs on Hypersensitivity vasculitis

Definitions

Definitions of Hypersensitivity vasculitis

Patient Resources / Community

Patient resources on Hypersensitivity vasculitis

Discussion groups on Hypersensitivity vasculitis

Patient Handouts on Hypersensitivity vasculitis

Directions to Hospitals Treating Hypersensitivity vasculitis

Risk calculators and risk factors for Hypersensitivity vasculitis

Healthcare Provider Resources

Symptoms of Hypersensitivity vasculitis

Causes & Risk Factors for Hypersensitivity vasculitis

Diagnostic studies for Hypersensitivity vasculitis

Treatment of Hypersensitivity vasculitis

Continuing Medical Education (CME)

CME Programs on Hypersensitivity vasculitis

International

Hypersensitivity vasculitis en Espanol

Hypersensitivity vasculitis en Francais

Business

Hypersensitivity vasculitis in the Marketplace

Patents on Hypersensitivity vasculitis

Experimental / Informatics

List of terms related to Hypersensitivity vasculitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]


Hypersensitivity vasculitis (or hypersensitivity angiitis or leukocytoclastic vasculitis) is usually due to a hypersensitivity reaction to a known drug, auto-antigens or infectious agents such as bacteria. Immune complexes lodge in the vessel wall, attracting polymorphonuclear leukocytes who in turn release tissue-degrading substances leading to an inflammatory process.

Clinical Presentation

Palpable, normally painful, petechiae or purpura (skin vasculitis). The lesions normally arise in crops, with common localizations being the forearms and legs. Necrosis of skin tissue can yield lesions with black or brown centres. This disorder may affect the skin only, but sometimes affect nerves, the kidneys, joints and the heart. Renal involvement is common.

Investigations

The primary goal is to identifiy the causing agent, be it a drug or a microbe. Questioning is important, as is a thorough physical examination, chest X-ray, ESR and biochemical organ tests. Skin biopsy of the lesions reveal inflammation of the small vessels, termed leukocytoclastic vasculitis, which is most prominent in postcapillary venules. Tests for hepatitis virus, antinuclear antibodies, rheumatoid factor and cryoglobulins might be indicated.

Diagnostic Criteria

At least 3 out of 5 criteria yields a sensitivity of 71% and a specificity of 84%:

  • Age >16.
  • Use of possible triggering drug in relation to symptoms.
  • Palpable painful purpura (the three P's).
  • Maculopapular rash.
  • Skin biopsy showing neutrophil infiltration around vessel.

Treatment

The most important part of the treatment is to eliminate the cause of the vasculitis, if at all possible. Antihistamines prove helpful to some patients. If the vasculitis is damaging organ systems such as the kidneys, immunosuppressive agents are indicated.

See also

External links

Template:GPnotebook

Template:Diseases of the musculoskeletal system and connective tissue


Template:WikiDoc Sources